Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 392 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Minor Trial completed
  3. Re-verified, no change to tracked fields
  4. Re-verified, no change to tracked fields
  5. Re-verified, no change to tracked fields
Show 45 earlier versionsHide 45 earlier versions
  1. New version filed on ClinicalTrials.gov
  2. 19 versions Re-verified since Mar 6, 2026, no change to tracked fieldsv368-v386
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 6000 to confirmed 4274
    v367
  4. 24 versions Re-verified since Mar 29, 2025, no change to tracked fieldsv343-v366
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Magnetic Resonance Imaging (MRI) unlike X-rays and CT-scans does not use radiation to create a picture. MRI use as the name implies, magnetism to create pictures with excellent anatomical resolution. Functional MRIs are diagnostic tests that allow doctors to not only view anatomy, but physiology and function. It is for these reasons that MRIs are excellent methods for studying the brain. In this study, researchers will use MRI to assess brain anatomy and function in X and Y chromosome variation, healthy volunteers, and patients with a variety of childhood onset psychiatric disorders. The disorders include attention deficit disorder, autism, congenital adrenal hyperplasia, childhood-onset schizophrenia, dyslexia, obsessive compulsive disorder, Sydenham's chorea, and Tourette's syndrome. Results of the MRIs showing the anatomy of the brain and brain function will be compared across age, sex (gender), and diagnostic groups. Correlations between brain and behavioral measures will be examined for normal and clinical populations.
Trial Details
NCT Number NCT00001246
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions
(from sponsor)
Attention Deficit Hyperactivity Disorder, Schizophrenia, Attention Deficit Disorder With Hyperactivity
Related terms Attention Deficit Disorder with Hyperactivity, Chorea, Schizophrenia
Enrollment 4,274 participants
Start Date
Updated on ClinicalTrials.gov